liposomal bcl-2 antisense oligonucleotide bp1002 vs idelalisib
| liposomal bcl-2 antisense oligonucleotide bp1002 | idelalisib | |
|---|---|---|
| Developers | 0 | 0 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | Liposomal Bcl-2 Antisense Oligonucleotide BP1002 | IDELALISIB |
| liposomal bcl-2 antisense oligonucleotide bp1002 | idelalisib | |
|---|---|---|
| Developers | 0 | 0 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | Liposomal Bcl-2 Antisense Oligonucleotide BP1002 | IDELALISIB |